Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: Nitric oxide

Nutrition Research

Volumn 32, Issue 8, 2012, Pages 557-564

  Larson, Abigail ^a   Witman, Melissa A H ^a,b   Guo, Yi ^c   Ives, Stephen ^a,b   Richardson, Russell S ^a,b,d   Bruno, Richard S ^c   Jalili, Thunder ^a   Symons, J David ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme; Clinical trial; Endothelin 1; Humans; Hypertension; Nitric oxide; Polyphenolic compounds; Quercetin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; NITRIC OXIDE; PLACEBO; QUERCETIN;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; HUMAN; HYPERTENSION; MALE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADULT; ARTERIAL PRESSURE; BRACHIAL ARTERY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIN-1; HUMANS; HYPERTENSION; MALE; NITRIC OXIDE; NITRITES; PEPTIDYL-DIPEPTIDASE A; PHYTOTHERAPY; PLANT EXTRACTS; QUERCETIN; VASODILATION; YOUNG ADULT;

EID: 84865567726     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.06.018     Document Type: Article

References (33)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De S.G., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121(7):e46-e215.
2. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117(4):e25-e146.
3. Hooper L., Kroon P., Rimm E., Cohn J., Harvey I., Le Cornu K., et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88(1):38-50.
4. Erdman J.W., Balentine D., Arab L., Beecher G., Dwyer J.T., Folts J., et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007, 137(3 Suppl 1):718S-737S.
5. Hodgson J.M., Croft K.D. Dietary flavonoids: effects on endothelial function and blood pressure. J Sci Food Agric 2006, 86:2492-2498.
6. Larson A.J., Symons J.D., Jalili T. Quercetin: A treatment for hypertension? A review of efficacy and mechanisms. Pharmaceuticals 2010, 3(1):237-250.
7. Carlstrom J., Symons J.D., Wu T.C., Bruno R.S., Litwin S.E., Jalili T. A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats. J Nutr 2007, 137:628-633.
8. Duarte J., Pérez-Palencia R., Vargas F., Ocete M.A., Pérez-Vizcaino F., Zarzuelo A., et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Brit J Pharm 2001, 113:117-124.
9. Yamamoto Y., Oue E. Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci Biotechnol Biochem 2006, 70(4):933-939.
10. Duarte J., Jimenez R., O'Valle F., Galisteo M., Perez-Palencia R., Vargas F., et al. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 2002, 20(9):1843-1854.
11. Hackl L.P., Cuttle G., Dovichi S.S., Lima-Landman M.T., Nicolau M. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to bradykinin and angiotensin I. Pharmacology 2002, 65(4):182-186.
12. Jalili T., Carlstrom J., Kim S., Freeman D., Jin H., Wu T.C., et al. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol 2006, 47:531-541.
13. Edwards R.L., Lyon T., Litwin S.E., Rabovsky A., Symons J.D., Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007, 137(11):2405-2411.
14. Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 2009, 102(7):1065-1074.
15. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360(9349):1903-1913.
16. Virdis A., Duranti E., Taddei S. Oxidative stress and vascular damage in hypertension: role of angiotensin II. Int J Hypertens 2011, 2011:1-7.
17. Touyz R.M., Schiffrin E.L. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004, 122(4):339-352.
18. Zhao X.Y., Gu Z.L. Effects of quercetin on production and release of endothelin and cGMP from cultured endothelial cells. Zhongguo Yao Li Xue Bao 1996, 17(5):442-444.
19. Nicholson S.K., Tucker G.A., Brameld J.M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc 2008, 67(1):42-47.
20. Sanchez M., Galisteo M., Vera R., Villar I., Zarzuelo A., Tamargo J., et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006, 24(1):75-84.
21. Loke W.M., Hodgson J.M., Proudfoot J.M., McKinley A.J., Puddey I.B., Croft K.D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 2008, 88(4):1018-1025.
22. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42(6):1206-1252.
23. Erlund I., Kosonen T., Alfthan G., Maenpaa J., Perttunen K., Kenraali J., et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000, 56(8):545-553.
24. Harris R.A., Nishiyama S.K., Wray D.W., Richardson R.S. Ultrasound assessment of flow-mediated dilation. Hypertension 2010, 55(5):1075-1085.
25. Chen C.Y., Milbury P.E., Lapsley K., Blumberg J.B. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr 2005, 135(6):1366-1373.
26. Wray D.W., Uberoi A., Lawrenson L., Richardson R.S. Heterogeneous limb vascular responsiveness to shear stimuli during dynamic exercise in humans. J Appl Physiol 2005, 99(1):81-86.
27. Hayman M.A., Nativi J.N., Stehlik J., McDaniel J., Fjeldstad A.S., Ives S.J., et al. Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol 2010, 299(5):H1653-H1659.
28. Faul F., Erdfelder E., Buchner A., Lang A.G. Statistical power analyses using G Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009, 41(4):1149-1160.
29. Egert S., Wolffram S., Schulze B., Langguth P., Hubbermann E.M., Schwarz K., et al. Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules. Br J Nutr 2011, 1-8.
30. Bohm F., Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007, 76(1):8-18.
31. Bondonno C.P., Yang X., Croft K.D., Considine M.J., Ward N.C., Rich L., et al. Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial. Free Radic Biol Med 2011, 52(1):95-102.
32. Harwood M., Danielewska-Nikiel B., Borzelleca J., Flamm G., Williams G., Lines T. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007, 45(11):2179-2205.
33. Choi J.S., Piao Y.J., Kang K.W. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 2011, 34(4):607-613.